Stereotactic Versus Standard Tumor Irradiation in Unresectable Locally Gevorderd Non-small Cell Longkanker With Durvalumab Maintenance: A Multicenter Studie With Propensity Score Matching

Tumor control in locally advanced non-small cell lung cancer (LA-NSCLC) is associated with patient prognosis, sustaining ongoing research in dose-escalation strategies. This study evaluates the efficacy and safety of tumor stereotactic body radiation therapy (T-SBRT) compared with tumoral normofractionated chemoradiation therapy followed by immunotherapy.